Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk.

Huang WY, Su LJ, Hayes RB, Moore LE, Katki HA, Berndt SI, Weissfeld JL, Yegnasubramanian S, Purdue MP.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2014-21. doi: 10.1158/1055-9965.EPI-12-0700-T. Epub 2012 Sep 20.

2.

Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study.

Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, Emery PW, Sanders TA.

Gastroenterology. 2003 May;124(5):1240-8.

PMID:
12730865
3.

Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women.

Nan H, Giovannucci EL, Wu K, Selhub J, Paul L, Rosner B, Fuchs CS, Cho E.

PLoS One. 2013;8(4):e59455. doi: 10.1371/journal.pone.0059455. Epub 2013 Apr 1.

4.

Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women.

Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, Sinha R, Katki HA, Cash B, Schoenfeld P, Stolzenberg-Solomon R.

Gastroenterology. 2008 Jan;134(1):47-55. doi: 10.1053/j.gastro.2007.10.013. Epub 2007 Oct 10.

5.

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N.

Lancet Oncol. 2008 Apr;9(4):359-66. doi: 10.1016/S1470-2045(08)70038-X. Epub 2008 Mar 12.

6.

Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.

Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R.

Cancer Res. 1997 Mar 15;57(6):1098-102.

7.

Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.

Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J.

J Natl Cancer Inst. 2005 May 4;97(9):684-92.

PMID:
15870439
8.

Global methylation of blood leukocyte DNA and risk of melanoma.

Shen J, Song R, Wan J, Huff C, Fang S, Lee JE, Zhao H.

Int J Cancer. 2017 Apr 1;140(7):1503-1509. doi: 10.1002/ijc.30577. Epub 2017 Jan 6.

PMID:
28006848
9.

Association between global DNA hypomethylation in leukocytes and risk of breast cancer.

Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, Nesline MK, Ambrosone CB, Karpf AR.

Carcinogenesis. 2009 Nov;30(11):1889-97. doi: 10.1093/carcin/bgp143. Epub 2009 Jul 7.

10.

LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.

Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE.

Epigenetics. 2014 Mar;9(3):404-15. doi: 10.4161/epi.27386. Epub 2013 Dec 6.

11.

Low folate levels are associated with reduced risk of colorectal cancer in a population with low folate status.

Gylling B, Van Guelpen B, Schneede J, Hultdin J, Ueland PM, Hallmans G, Johansson I, Palmqvist R.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2136-44. doi: 10.1158/1055-9965.EPI-13-1352. Epub 2014 Jul 25.

12.

Folate, methionine, and alcohol intake and risk of colorectal adenoma.

Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC.

J Natl Cancer Inst. 1993 Jun 2;85(11):875-84.

PMID:
8492316
13.

Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer.

Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, Steele RJ, Carey FA, Key TJ, Wolf R, Forman D.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2421-30. doi: 10.1158/1055-9965.EPI-08-0058. Epub 2008 Aug 14.

14.

Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas.

van den Donk M, van Engeland M, Pellis L, Witteman BJ, Kok FJ, Keijer J, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):327-33.

15.

Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.

Mendoza-Pérez J, Gu J, Herrera LA, Tannir NM, Matin SF, Karam JA, Huang M, Chang DW, Wood CG, Wu X.

Clin Cancer Res. 2016 Apr 15;22(8):2074-82. doi: 10.1158/1078-0432.CCR-15-0977. Epub 2015 Dec 11.

16.

Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk.

Friso S, Udali S, Guarini P, Pellegrini C, Pattini P, Moruzzi S, Girelli D, Pizzolo F, Martinelli N, Corrocher R, Olivieri O, Choi SW.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):348-55. doi: 10.1158/1055-9965.EPI-12-0859. Epub 2013 Jan 8.

17.

LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.

Karami S, Andreotti G, Liao LM, Pfeiffer RM, Weinstein SJ, Purdue MP, Hofmann JN, Albanes D, Mannisto S, Moore LE.

Epigenetics. 2015;10(4):282-92. doi: 10.1080/15592294.2015.1006505. Epub 2015 Feb 3.

18.

Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients.

Kim JW, Park HM, Choi YK, Chong SY, Oh D, Kim NK.

Oncol Rep. 2011 Jan;25(1):167-72.

PMID:
21109973
19.

Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa.

Liu J, Hesson LB, Meagher AP, Bourke MJ, Hawkins NJ, Rand KN, Molloy PL, Pimanda JE, Ward RL.

Cancer Prev Res (Phila). 2012 Jul;5(7):921-9. doi: 10.1158/1940-6207.CAPR-11-0577. Epub 2012 May 18.

20.

Dietary folate and APC mutations in sporadic colorectal cancer.

de Vogel S, van Engeland M, Lüchtenborg M, de Bruïne AP, Roemen GM, Lentjes MH, Goldbohm RA, van den Brandt PA, de Goeij AF, Weijenberg MP.

J Nutr. 2006 Dec;136(12):3015-21.

Supplemental Content

Support Center